|Bid||437.71 x 1200|
|Ask||437.94 x 1000|
|Day's range||429.34 - 438.38|
|52-week range||269.01 - 438.38|
|Beta (5Y monthly)||1.04|
|PE ratio (TTM)||23.45|
|Forward dividend & yield||4.52 (1.21%)|
|Ex-dividend date||09 Sept 2021|
|1y target est||N/A|
Anthem, Inc. (NYSE:ANTM) seems to have been a great long-term investment, as evident by the stock being up 257% in five years. Additionally, the share price has risen 14% in thirty days, resulting from the latest earnings release. We will go over the performance of the bottom line as it relates to providing free cash flows to investors, and see how the future potential fares.
This is Steve Tanal Vice President of Investor Relations and with us this morning on the earnings call are Gail Boudreaux, President and CEO, John Gallina our CFO, Peter Haytaian, President of our Diversified Business Group and IngenioRx; Morgan Kendrick, President of our Commercial and Specialty Business Division and Felicia Norwood, President of our Government Business Division. As a result our focus on reducing health disparities and inequities remains vital to the value Anthem offers their partners [Phonetic].